A phase IIa, randomized, double-blind, placebo-controlled, parallel group study to assess pharmacodynamics, pharmacokinetics, safety and tolerability of oral multiple ascending doses of AZD0328 in patients with schizophrenia

Trial Profile

A phase IIa, randomized, double-blind, placebo-controlled, parallel group study to assess pharmacodynamics, pharmacokinetics, safety and tolerability of oral multiple ascending doses of AZD0328 in patients with schizophrenia

Discontinued
Phase of Trial: Phase II

Latest Information Update: 09 Aug 2010

At a glance

  • Drugs AZD 0328 (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jul 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 15 Oct 2008 Status changed from recruiting to active, no longer recruiting as reported by the ClinicalTrials.gov record.
    • 23 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top